TODD E SIMPSON
CIK 1216477 · Chief Financial Officer · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$484.8K
Companies
4
Total Filings
91
Lifetime Open-Market Net
-$93.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XNCR | Director | 23,988 | $20.21 | $484.8K | $0 | 3 | 2026-07-08 |
| Seagen Inc. (SGEN) Delisted | Chief Financial Officer | 0 | $228.74 | $0 | -$93.80M | 72 | 2023-12-15 |
| Neurogene Inc. (NLTX) Delisted | Director | — | $13.96 | — | $0 | 5 | 2023-06-09 |
| Neurogene Inc. (AQXP) Delisted | Director | — | — | — | $0 | 5 | 2018-05-09 |
Recent Filings · Page 7 of 10
91 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-08-30 | Seagen Inc. (SGEN) Delisted | Grant (A) | +18,000 | $0 | EDGAR |
| 2016-08-22 | Seagen Inc. (SGEN) Delisted | Sell (S) | −3,991 | -$185.9K | EDGAR |
| 2016-05-11 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-10-01 | Seagen Inc. (SGEN) Delisted | Exer (M) | +14,801 | $200.0K | EDGAR |
| 2015-08-25 | Seagen Inc. (SGEN) Delisted | Mixed | +11,175 | -$244.8K | EDGAR |
| 2015-03-16 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-08-27 | Seagen Inc. (SGEN) Delisted | Mixed | +13,304 | -$161.0K | EDGAR |
| 2014-03-10 | Neurogene Inc. (AQXP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-08-30 | Seagen Inc. (SGEN) Delisted | Mixed | +30,366 | -$217.7K | EDGAR |
| 2013-08-21 | Seagen Inc. (SGEN) Delisted | Mixed | +11,072 | -$136.1K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.